Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 4/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | PNMT | P11086 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | TDO2 | P48775 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL348089 | 0.88 | CYP3A4 (0.62) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| SCHEMBL29368277 | 0.88 | CYP3A4 (0.62) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| Hydrochloric Acid SCHEMBL27691381 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| Phosphine SCHEMBL28064314 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| SCHEMBL28338848 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| Methane SCHEMBL23466796 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| SCHEMBL27259983 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| Ammonia Solution, Strong SCHEMBL28194262 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| Fluoride SCHEMBL27699550 | 0.84 | CYP3A4 (0.59) | CYP3A4MAPK1CYP2A6CYP1A2TSHR | |
| SCHEMBL10489573 | 0.81 | TSHR (0.55) | CYP3A4MAPK1CYP2A6CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2868659-B1 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORP (JP) | 2016-05-04 | — | — | EP | claimed |
| US-9181217-B2 | Method for producing optically active naphthalene compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-11-10 | — | — | US | claimed |
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2015-06-04 | — | — | US | claimed |
| EP-2868659-A1 | Method for producing optically active naphthalene compound | Mitsubishi Tanabe Pharma Corporation (JP) | 2015-05-06 | — | — | EP | claimed |
| EP-2749558-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2014-07-02 | — | — | EP | claimed |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2013-09-12 | — | — | US | claimed |
| EP-1944291-B1 | Optically active cyclic alcohol compound and method for producing same | MITSUBISHI TANABE PHARMA CORP (JP) | 2012-06-13 | — | — | EP | claimed |
| US-20100152451-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2010-06-17 | — | — | US | claimed |
| EP-1944291-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PRODUCING SAME | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-07-16 | — | — | EP | claimed |
| US-20230416173-A1 | Distillation Process and Apparatus with Pressure Corrected Temperature Heat Source Control | INEOS ACETYLS UK LIMITED (GB) | 2023-12-28 | — | — | US | disclosed |
| US-20230415065-A1 | Processes and Apparatuses for Distillation of an Acetic Acid and Propionic Acid-Containing Stream in an Acetic Acid Production Unit | INEOS ACETYLS UK LIMITED (GB) | 2023-12-28 | — | — | US | disclosed |
| US-20230338888-A1 | Processes for Treating Off-Gas In An Acetic Acid Production Unit | INEOS ACETYLS UK LIMITED (GB) | 2023-10-26 | — | — | US | disclosed |
| US-20230150908-A1 | Process for Producing Acetic Acid | INEOS ACETYLS UK LIMITED (GB) | 2023-05-18 | — | — | US | disclosed |
| US-20230052743-A1 | Separation Process and Apparatus | INEOS ACETYLS UK LIMITED (GB) | 2023-02-16 | — | — | US | disclosed |
| EP-0768295-A1 | PROCESS FOR PRODUCING ACETIC ACID | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1997-04-16 | — | — | EP | disclosed |
| EP-0752406-A1 | Process for the production of acetic acid by carbonylation | BP Chemicals Limited (GB) | 1997-01-08 | — | — | EP | disclosed |
| EP-0749948-A1 | Process for the carbonylation of alkyl alcohols and/or reactive derivatives thereof | BP Chemicals Limited (GB) | 1996-12-27 | — | — | EP | disclosed |
| EP-0728727-A1 | Process for the carbonylation of an alcohol | BP Chemicals Limited (GB) | 1996-08-28 | — | — | EP | disclosed |
| EP-0728729-A1 | Process for purifying a carboxylic acid | BP Chemicals Limited (GB) | 1996-08-28 | — | — | EP | disclosed |
| EP-0643034-A1 | Process for the production of acetic acid | BP Chemicals Limited (GB) | 1995-03-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152082-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE NAPHTHALENE COMPOUND | HRH1, HRH4, RB1 | CYP3A4 1794/4885MAPK1 416/4885CYP2A6 1879/4885 |
| US-20100152451-A1 | OPTICALLY ACTIVE CYCLIC ALCOHOL COMPOUND AND METHOD FOR PREPARING THE SAME | ADH1C, ADH1A, ADH5 | CYP3A4 277/4885MAPK1 732/4885CYP2A6 1251/4885 |
| US-20130237708-A1 | Optically Active Cyclic Alcohol Compound And Method For Preparing The Same | ADH1C, ADH1A, ADH5 | CYP3A4 277/4885MAPK1 732/4885CYP2A6 1251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.